Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.040
+0.170 (9.09%)
At close: Nov 9, 2026, 4:00 PM EST
2.050
+0.010 (0.49%)
Pre-market: Nov 10, 2026, 4:59 AM EST
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $122.32 million as of November 9, 2026. It is the 23,636th most valuable company in the world and the 3,927th biggest in the United States. Its market cap has decreased by 50.39% in one year.
Market Cap
122.32M
Enterprise Value
9.97M
1-Year Change
-50.39%
Global Rank
Country Rank
#3,927 United States
Category
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $122.32M, a decrease of -78.37%. That is a compound annual growth rate of -22.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 122.32M | -59.94% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| enGene Therapeutics | 117.28M |
| OnKure Therapeutics | 116.04M |
| Minerva Neurosciences | 115.55M |
| Voyager Therapeutics | 114.92M |
| Anixa Biosciences | 110.38M |
| LENZ Therapeutics | 109.97M |
| Milestone Pharmaceuticals | 107.49M |
| Anavex Life Sciences | 106.60M |